Atlas Trials

Effects of Switching Efavirenz to Raltegravir on Vascular Function and Bone Markers in HIV-infected Patients

Clinical trial NCT01270802 · COMPLETED

Trial details

NCT number
NCT01270802
Sponsor
Indiana University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HIV
Start date
2011-04-01
Primary completion
2012-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.